Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • TWilliamson
    Junior Member
    • Sep 2017
    • 1

    #1

    Different cell-lines giving different levels of uniquely mapped reads?

    Hi all,

    We are carrying out some RNA-Seq on the full transcriptome of a cell line (x) and a cell line derived xenograft (y). RNA was harvested from x, half of it was taken and heat treated to degrade the RNA, bringing the RIN from 9.5 to 4.5. A freshly frozen CDX sample from y and an FFPE CDX sample for y also had their RNA harvested; the RIN was 9.5 and 2.5 respectively.
    To quickly summarise:
    Cell line (x): RIN 9.5 and 4.5
    CDX (y): RIN 9.5 and 2.5

    All 4 samples were put through three different library prep protocols (skipping any RNA degradation steps for the degraded samples) and then sequenced. Upon alignment analysis, both samples from x have more 'uniquely mapped reads' and less 'unmapped: too short' reads, with about the same number of 'mapped to too many loci' reads. Alignment of the degraded x RNA sample also seems to be better than the intact y RNA sample...

    The quality of alignment seems to be much better with samples from x in all three protocols, despite being treated the same as the other samples. I'm fairly certain that the DV200 score was also similar throughout all samples before library prep. What could be causing this?

    It might be worth adding that the cell line is a cancer cell line and the CDX is a cancer biopsy (derived from a different cell line). Could the differential gene expression have some effect?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Working...